Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide

N. R F Nascimento, L. M A Lessa, M. R. Kerntopf, C. M. Sousa, R. S. Alves, M. G R Queiroz, J. Price, D. B. Heimark, J. Larner, Xue-Liang Du, M. Brownlee, A. Gow, C. Davis, M. C. Fonteles

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Endothelial dysfunction (ED) is an early feature of cardiovascular risk and diabetes. Hyperglycemic and hyperlipidemia are causative factors. Excessive endothelial mitochondrial superoxide (ROS) production with hyperglycemia and hyperlipidemia is a key mechanism. Inositol components of an insulin inositol glycan mediator, D-chiro-inositol (DCI) and 3-O-methyl DCI (pinitol), decrease hyperglycemia and hyperlipidemia. We tested whether these, myoinositol and dibutyryl DCI (db-DCI), would prevent or reverse ED in diabetic rats and rabbits. Oral inositols reduced hyperglycemia and hypertriglyceridemia with different potencies and prevented ED in rat aortic rings and mesenteric beds. Inositols added in vitro to five diabetic tissues reversed ED. Relaxation by Ach, NO, and electrical field stimulation was potentiated by inositols in vitro in rabbit penile corpus cavernosa. Inositols in vitro restored impaired contraction by the eNOS inhibitor L-NAME and increased NO effectiveness. DCI and db-DCI decreased elevated ROS in endothelial cells in high glucose and db-DCI reduced PKC activation, hexosamine pathway activity, and advanced glycation end products to basal levels. Xanthine/xanthine oxidase generated superoxide was reduced by superoxide dismutase or inositols, with db-DCI efficacious in a mechanism requiring chelated Fe3+. Histochemical examination of rat aortic rings for protein SNO demonstrated a decrease in diabetic rings with restoration by inositols. In summary, inositols prevented and reversed ED in rat and rabbit vessels, reduced elevated ROS in endothelial cells, potentiated nitrergic or vasculo-myogenic relaxations, and preserved NO signaling. These effects are related to their metabolic actions, direct superoxide scavenging, and enhancing and protecting NO signaling. Of the inositols tested, db-DCI was most effective.

Original languageEnglish (US)
Pages (from-to)218-223
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume103
Issue number1
DOIs
StatePublished - Jan 3 2006

Fingerprint

Inositol
Superoxides
Rabbits
Hyperlipidemias
Hyperglycemia
Endothelial Cells
Hexosamines
Advanced Glycosylation End Products
Xanthine
Xanthine Oxidase
Hypertriglyceridemia
NG-Nitroarginine Methyl Ester
Electric Stimulation
Superoxide Dismutase
Insulin
Glucose

Keywords

  • D-chiro-inositol
  • Diabetes
  • Insulin
  • Mimetic
  • NO

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. / Nascimento, N. R F; Lessa, L. M A; Kerntopf, M. R.; Sousa, C. M.; Alves, R. S.; Queiroz, M. G R; Price, J.; Heimark, D. B.; Larner, J.; Du, Xue-Liang; Brownlee, M.; Gow, A.; Davis, C.; Fonteles, M. C.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 1, 03.01.2006, p. 218-223.

Research output: Contribution to journalArticle

Nascimento, NRF, Lessa, LMA, Kerntopf, MR, Sousa, CM, Alves, RS, Queiroz, MGR, Price, J, Heimark, DB, Larner, J, Du, X-L, Brownlee, M, Gow, A, Davis, C & Fonteles, MC 2006, 'Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide', Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 1, pp. 218-223. https://doi.org/10.1073/pnas.0509779103
Nascimento, N. R F ; Lessa, L. M A ; Kerntopf, M. R. ; Sousa, C. M. ; Alves, R. S. ; Queiroz, M. G R ; Price, J. ; Heimark, D. B. ; Larner, J. ; Du, Xue-Liang ; Brownlee, M. ; Gow, A. ; Davis, C. ; Fonteles, M. C. / Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. In: Proceedings of the National Academy of Sciences of the United States of America. 2006 ; Vol. 103, No. 1. pp. 218-223.
@article{e8e892dfefec4e09888f2767a8960627,
title = "Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide",
abstract = "Endothelial dysfunction (ED) is an early feature of cardiovascular risk and diabetes. Hyperglycemic and hyperlipidemia are causative factors. Excessive endothelial mitochondrial superoxide (ROS) production with hyperglycemia and hyperlipidemia is a key mechanism. Inositol components of an insulin inositol glycan mediator, D-chiro-inositol (DCI) and 3-O-methyl DCI (pinitol), decrease hyperglycemia and hyperlipidemia. We tested whether these, myoinositol and dibutyryl DCI (db-DCI), would prevent or reverse ED in diabetic rats and rabbits. Oral inositols reduced hyperglycemia and hypertriglyceridemia with different potencies and prevented ED in rat aortic rings and mesenteric beds. Inositols added in vitro to five diabetic tissues reversed ED. Relaxation by Ach, NO, and electrical field stimulation was potentiated by inositols in vitro in rabbit penile corpus cavernosa. Inositols in vitro restored impaired contraction by the eNOS inhibitor L-NAME and increased NO effectiveness. DCI and db-DCI decreased elevated ROS in endothelial cells in high glucose and db-DCI reduced PKC activation, hexosamine pathway activity, and advanced glycation end products to basal levels. Xanthine/xanthine oxidase generated superoxide was reduced by superoxide dismutase or inositols, with db-DCI efficacious in a mechanism requiring chelated Fe3+. Histochemical examination of rat aortic rings for protein SNO demonstrated a decrease in diabetic rings with restoration by inositols. In summary, inositols prevented and reversed ED in rat and rabbit vessels, reduced elevated ROS in endothelial cells, potentiated nitrergic or vasculo-myogenic relaxations, and preserved NO signaling. These effects are related to their metabolic actions, direct superoxide scavenging, and enhancing and protecting NO signaling. Of the inositols tested, db-DCI was most effective.",
keywords = "D-chiro-inositol, Diabetes, Insulin, Mimetic, NO",
author = "Nascimento, {N. R F} and Lessa, {L. M A} and Kerntopf, {M. R.} and Sousa, {C. M.} and Alves, {R. S.} and Queiroz, {M. G R} and J. Price and Heimark, {D. B.} and J. Larner and Xue-Liang Du and M. Brownlee and A. Gow and C. Davis and Fonteles, {M. C.}",
year = "2006",
month = "1",
day = "3",
doi = "10.1073/pnas.0509779103",
language = "English (US)",
volume = "103",
pages = "218--223",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "1",

}

TY - JOUR

T1 - Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide

AU - Nascimento, N. R F

AU - Lessa, L. M A

AU - Kerntopf, M. R.

AU - Sousa, C. M.

AU - Alves, R. S.

AU - Queiroz, M. G R

AU - Price, J.

AU - Heimark, D. B.

AU - Larner, J.

AU - Du, Xue-Liang

AU - Brownlee, M.

AU - Gow, A.

AU - Davis, C.

AU - Fonteles, M. C.

PY - 2006/1/3

Y1 - 2006/1/3

N2 - Endothelial dysfunction (ED) is an early feature of cardiovascular risk and diabetes. Hyperglycemic and hyperlipidemia are causative factors. Excessive endothelial mitochondrial superoxide (ROS) production with hyperglycemia and hyperlipidemia is a key mechanism. Inositol components of an insulin inositol glycan mediator, D-chiro-inositol (DCI) and 3-O-methyl DCI (pinitol), decrease hyperglycemia and hyperlipidemia. We tested whether these, myoinositol and dibutyryl DCI (db-DCI), would prevent or reverse ED in diabetic rats and rabbits. Oral inositols reduced hyperglycemia and hypertriglyceridemia with different potencies and prevented ED in rat aortic rings and mesenteric beds. Inositols added in vitro to five diabetic tissues reversed ED. Relaxation by Ach, NO, and electrical field stimulation was potentiated by inositols in vitro in rabbit penile corpus cavernosa. Inositols in vitro restored impaired contraction by the eNOS inhibitor L-NAME and increased NO effectiveness. DCI and db-DCI decreased elevated ROS in endothelial cells in high glucose and db-DCI reduced PKC activation, hexosamine pathway activity, and advanced glycation end products to basal levels. Xanthine/xanthine oxidase generated superoxide was reduced by superoxide dismutase or inositols, with db-DCI efficacious in a mechanism requiring chelated Fe3+. Histochemical examination of rat aortic rings for protein SNO demonstrated a decrease in diabetic rings with restoration by inositols. In summary, inositols prevented and reversed ED in rat and rabbit vessels, reduced elevated ROS in endothelial cells, potentiated nitrergic or vasculo-myogenic relaxations, and preserved NO signaling. These effects are related to their metabolic actions, direct superoxide scavenging, and enhancing and protecting NO signaling. Of the inositols tested, db-DCI was most effective.

AB - Endothelial dysfunction (ED) is an early feature of cardiovascular risk and diabetes. Hyperglycemic and hyperlipidemia are causative factors. Excessive endothelial mitochondrial superoxide (ROS) production with hyperglycemia and hyperlipidemia is a key mechanism. Inositol components of an insulin inositol glycan mediator, D-chiro-inositol (DCI) and 3-O-methyl DCI (pinitol), decrease hyperglycemia and hyperlipidemia. We tested whether these, myoinositol and dibutyryl DCI (db-DCI), would prevent or reverse ED in diabetic rats and rabbits. Oral inositols reduced hyperglycemia and hypertriglyceridemia with different potencies and prevented ED in rat aortic rings and mesenteric beds. Inositols added in vitro to five diabetic tissues reversed ED. Relaxation by Ach, NO, and electrical field stimulation was potentiated by inositols in vitro in rabbit penile corpus cavernosa. Inositols in vitro restored impaired contraction by the eNOS inhibitor L-NAME and increased NO effectiveness. DCI and db-DCI decreased elevated ROS in endothelial cells in high glucose and db-DCI reduced PKC activation, hexosamine pathway activity, and advanced glycation end products to basal levels. Xanthine/xanthine oxidase generated superoxide was reduced by superoxide dismutase or inositols, with db-DCI efficacious in a mechanism requiring chelated Fe3+. Histochemical examination of rat aortic rings for protein SNO demonstrated a decrease in diabetic rings with restoration by inositols. In summary, inositols prevented and reversed ED in rat and rabbit vessels, reduced elevated ROS in endothelial cells, potentiated nitrergic or vasculo-myogenic relaxations, and preserved NO signaling. These effects are related to their metabolic actions, direct superoxide scavenging, and enhancing and protecting NO signaling. Of the inositols tested, db-DCI was most effective.

KW - D-chiro-inositol

KW - Diabetes

KW - Insulin

KW - Mimetic

KW - NO

UR - http://www.scopus.com/inward/record.url?scp=30444434037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30444434037&partnerID=8YFLogxK

U2 - 10.1073/pnas.0509779103

DO - 10.1073/pnas.0509779103

M3 - Article

VL - 103

SP - 218

EP - 223

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 1

ER -